|
Biomarkers of Exposure and Effect in Agriculture (BEEA)
|
Research Initiative
|
CDC
|
NCI
|
National Cancer Institute (NCI) and the Centers for Disease Control and Prevention (CDC) are collaborating to characterize exposure to permethrin and other pesticides by measuring urinary metabolites among participants in the Biomarkers of Exposure and Effect in Agriculture (BEEA) study.
|
|
Biomarkers of Exposure and Effect in Agriculture (Water Contaminants)
|
Research Initiative
|
CDC
|
NCI
|
National Cancer Institute (NCI) and the Centers for Disease Control and Prevention (CDC) and the US Geological Survey (USGS) are collaborating on a study characterize exposure to water contaminants by measuring urinary nitrate excretion, and drinking water concentrations of nitrate, pesticides, and other chemicals, as well as hormone activity among a subset of participants in the Biomarkers of Exposure and Effect in Agriculture (BEEA) study.
|
|
Biomedical Studies and Cellular Imaging via Atomic Force Microscopy
|
Research Initiative
|
FDA
|
OD/OIR, NIBIB
|
Biomedical Studies and Cellular Imaging via Atomic Force Microscopy
|
|
Blood Products Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
CC, NHLBI
|
The Food and Drug Administration (FDA) Blood Products Advisory Committee (BPAC) reviews and evaluates available data concerning the safety, effectiveness, and appropriate use of blood, products derived from blood and serum or biotechnology which are intended for use in the diagnosis, prevention, or treatment of human diseases, and, as required, any other product for which the Food and Drug Administration has regulatory responsibility. The committee also advises the Commissioner of Food and Drugs of its findings.
|
|
Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NIAID, CC, NIAID7, NHLBI
|
The Blood, Organ, and Tissue Senior Executive Council (BOTSEC) is an advisory forum for senior leadership from the Department of Health and Human Services (HHS) organizational components, as well as liaison representatives from Department of Defense and Veterans’ Health Administration, that are involved in blood, organ, and tissue safety and availability. The HHS Assistant Secretary for Health serves as the Council Chair, and the Office of the Assistant Secretary for Health (OASH) Senior Advisor for Blood and Tissue Policy serves as the BOTSEC Executive Director.
|
|
Board of Scientific Counselors (BSC) of the CDC National Center for Injury Prevention and Control
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, CDC, HRSA, IHS, SAMHSA
|
NICHD, NIA, NIDA, NIMH
|
The BSC advises the Secretary, Department of Health and Human Services; the Director, Centers for Disease Control and Prevention (CDC); and the Director, National Center for Injury Prevention and Control (NCIPC) regarding surveillance, basic epidemiologic research, intervention research, and implementation, dissemination, and evaluation of promising and evidence-based strategies for the prevention of injury and violence. The Board makes recommendations regarding policies, strategies, objectives, projects, and priorities, and reviews progress toward injury and violence prevention.
|
|
Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD
|
The Committee reviews and evaluates data on the safety and effectiveness of marketed and investigational human drug products for use in the practice of osteoporosis and metabolic bone disease, obstetrics, gynecology, urology and related specialties, and makes appropriate recommendations to the Commissioner of Food and Drugs.
|
|
Botanical Safety Consortium
|
Research Initiative
|
FDA
|
NIEHS, NCCIH
|
Public-private partnership aimed at developing an in vitro toolkit for evaluating botanical safety
|
|
Botulism Guidelines Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
CC
|
The National Institutes of Health (NIH) Clinical Center is participating in a working group with the Centers for Disease Control and Prevention (CDC) to develop clinical guidelines for treatment of botulism and use of botulism antitoxin.
|
|
Brain Attack Coalition (BAC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NINDS
|
The Brain Attack Coalition (BAC) is a group of public and private entities representing medical, scientific, advocacy, and government professionals from across the stroke continuum. The BAC is dedicated to setting direction, advancing knowledge, and communicating best practices to improve our ability to prevent and combat stroke.
|